Legislative Activity

The Foreign Propaganda Disclosure Act amends the Foreign Agents Registration Act (FARA) to explicitly include social media influencers within the definition of foreign agents. This legislation requires influencers with monetized accounts to register with the U.S. government if they are acting on behalf of foreign principals. The bill aims to increase transparency regarding foreign-backed content across social media platforms.

The RESCUE Act of 2026 updates Medicare payment rates for ground and air ambulance services to better reflect the actual costs of providing emergency care. The bill mandates regular rate adjustments based on current operational data, expands cost-reporting requirements for air ambulance providers, and establishes a stakeholder commission to ensure the long-term adequacy of ambulance service reimbursement.

The Stop Insider Trading Act restricts Members of Congress, their spouses, and dependent children from purchasing or selling individual stocks to prevent conflicts of interest. Additionally, the bill mandates that voters provide valid photo identification when voting in person or by mail in federal elections.

The ORTHO Act mandates that dentists conduct an in-person examination before providing teledentistry services, with limited exceptions for emergent care, public health programs, and initial orthodontic diagnoses. The bill empowers the Federal Trade Commission and state attorneys general to enforce these safety standards, treating violations as unfair or deceptive acts. By requiring professional clinical oversight, the legislation ensures that remote dental care meets established safety and diagnostic requirements.

The "Combating Illicit Xylazine Act" aims to combat the illegal use of xylazine by adding it to Schedule III of the Controlled Substances Act, which would allow for increased regulation and tracking of the substance. The bill includes exemptions and delayed effective dates for certain requirements to ease the transition for legitimate users, such as veterinarians and animal handlers. It also directs the Sentencing Commission to review sentencing guidelines for xylazine-related offenses and mandates reports to Congress on the prevalence and impact of illicit xylazine use. Finally, it will include xylazine in Arcos tracking.

The Ratepayer Protection Act establishes a new federal standard requiring electric utilities to ensure large industrial customers (100 MW or more) fully cover the costs of necessary infrastructure upgrades. This mandates that large-load customers provide financial assurances before construction begins, protecting existing ratepayers from bearing the risk of future contract terminations. States must consider and adopt this standard within two years, unless they have already implemented similar requirements.

The Load Forecasting Enhancement Act establishes regional joint boards to study and identify best practices for electric load forecasting to improve grid reliability and affordability. It then mandates that electric utilities incorporate these best practices into their forecasting methods through an amendment to PURPA. Finally, the bill requires states to update their energy conservation plans to include procedures for improving load forecasting accuracy and transparency.

The AADAPT Act expands access to specialized dementia care by authorizing grants for public and nonprofit health centers to integrate these services into their programs. Additionally, the bill extends federal funding authorization through 2031 to ensure the continued growth and sustainability of these critical health outcomes.

The Improving Seniors’ Timely Access to Care Act of 2025 aims to streamline and modernize the prior authorization process within Medicare Advantage plans. This bill mandates the adoption of electronic prior authorization systems and significantly increases transparency regarding approval rates and decision times starting in 2027. Furthermore, it establishes new enrollee protections and grants the Secretary authority to enforce faster decision timeframes for medical services.

The SECURE 340B Act establishes a comprehensive framework to increase transparency, accountability, and oversight within the 340B drug pricing program. The bill introduces clear definitions for patient eligibility, mandates rigorous reporting and auditing standards for covered entities and contract pharmacies, and prohibits discriminatory practices by health plans and pharmacy benefit managers. Additionally, it implements new patient affordability protections and creates a data clearinghouse to prevent duplicate discounts and ensure program integrity.

The Kidney Disease Education Access Expansion Act of 2026 significantly broadens access to and coverage of kidney disease education services under both Medicare and private health insurance. This legislation expands eligibility for services, allows for group and telehealth delivery, and mandates coverage for these preventive services without patient cost-sharing. Furthermore, it removes session limits and establishes a working group to assess and improve the effectiveness of these educational programs.

The Access to Innovative Treatments Act of 2026 establishes a new, expedited review process for Medicare National Coverage Determinations (NCDs) that restrict coverage for FDA-approved drugs or biologicals. This bill mandates that the Secretary of HHS review challenged NCDs within strict timelines and prevents Part D plans from using these restrictive NCDs to deny coverage for approved treatments. The goal is to ensure Medicare coverage aligns with the drug's official FDA approval status.

The Medicare Advantage Cost Transparency Act mandates that Medicare Advantage plans report detailed financial information, including contracted rates and member cost-sharing amounts, within their encounter data starting in 2027. This legislation also requires plans to disclose whether their members received specific types of at-home health risk assessments during the plan year. The goal is to increase transparency regarding costs and assessment activities within Medicare Advantage plans.

This resolution expresses support for designating the first week of June as "Hidradenitis Suppurativa Awareness Week." The goal is to increase public and professional understanding of this painful, often misdiagnosed chronic skin condition. This designation aims to promote timely diagnosis, support vital research, and improve access to care for the millions affected.

The Provider Reimbursement Stability Act of 2026 aims to improve the accuracy and predictability of Medicare physician payments. The bill reforms budget neutrality calculations, mandates periodic updates to practice expense cost data, and establishes a 2.5% cap on annual conversion factor fluctuations. These measures are designed to ensure more stable reimbursement rates for healthcare providers.

This bill, the Small Practice, Underserved, and Rural Support Program Extension Act of 2026, extends crucial funding for the Quality Payment Program-Small Practice, Underserved, and Rural Support program. This extension ensures continued support for small medical practices and providers serving in underserved and rural communities. The funding authorization is extended through fiscal year 2031.

This bill, the SCREEN for Type 1 Diabetes Act of 2026, mandates the creation of a national public awareness campaign to promote the detection, screening, and management of type 1 diabetes. The campaign will utilize evidence-based materials and public service announcements targeted at both healthcare providers and the general public. It also authorizes funding for grants to support local efforts in increasing screening rates, particularly in highly affected communities.

The Combating Organized Retail Crime Act of 2025 aims to combat sophisticated, cross-jurisdictional organized retail and supply chain theft. It achieves this by strengthening federal laws regarding money laundering and stolen property offenses, including lowering monetary thresholds for prosecution. Furthermore, the bill establishes a dedicated Center within the Department of Homeland Security to coordinate federal, state, and local enforcement efforts against these criminal organizations.

The Repealing Big Brother Overreach Act significantly narrows the federal beneficial ownership information reporting requirements. This legislation limits reporting obligations exclusively to foreign individuals and foreign-connected companies. Furthermore, it mandates the deletion of all previously collected data pertaining to domestic persons and entities.

The Strengthening the Vaccines for Children Program Act of 2026 aims to expand access to childhood immunizations by broadening eligibility for the VFC program and setting minimum payment rates for vaccine administration under Medicaid and CHIP. The bill mandates that Medicaid and CHIP programs pay providers at least 100% of the Medicare Part B rate for vaccine administration and counseling services through 2028. Additionally, it increases the federal Medicaid matching rate contingent upon states implementing culturally competent vaccination outreach efforts.